X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Torrent Pharma with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs CADILA HEALTHCARE - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA CADILA HEALTHCARE TORRENT PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x 34.0 23.7 143.3% View Chart
P/BV x 5.1 5.3 97.3% View Chart
Dividend Yield % 1.1 0.9 118.9%  

Financials

 TORRENT PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-17
CADILA HEALTHCARE
Mar-17
TORRENT PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,768460 384.3%   
Low Rs1,186305 388.7%   
Sales per share (Unadj.) Rs346.192.1 375.8%  
Earnings per share (Unadj.) Rs55.214.8 372.4%  
Cash flow per share (Unadj.) Rs73.318.5 396.7%  
Dividends per share (Unadj.) Rs14.003.20 437.5%  
Dividend yield (eoy) %0.90.8 113.3%  
Book value per share (Unadj.) Rs257.168.0 378.1%  
Shares outstanding (eoy) m169.221,023.74 16.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.34.2 102.7%   
Avg P/E ratio x26.825.8 103.7%  
P/CF ratio (eoy) x20.120.7 97.3%  
Price / Book Value ratio x5.75.6 102.1%  
Dividend payout %25.421.6 117.5%   
Avg Mkt Cap Rs m249,887391,581 63.8%   
No. of employees `00011.816.9 69.9%   
Total wages/salary Rs m9,93415,002 66.2%   
Avg. sales/employee Rs Th4,971.55,594.5 88.9%   
Avg. wages/employee Rs Th843.2890.1 94.7%   
Avg. net profit/employee Rs Th792.4899.9 88.1%   
INCOME DATA
Net Sales Rs m58,56994,295 62.1%  
Other income Rs m2,2331,286 173.6%   
Total revenues Rs m60,80295,581 63.6%   
Gross profit Rs m13,77319,036 72.4%  
Depreciation Rs m3,0693,750 81.8%   
Interest Rs m2,056450 456.8%   
Profit before tax Rs m10,88116,122 67.5%   
Minority Interest Rs m0338 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3 0.0%   
Tax Rs m1,5451,289 119.9%   
Profit after tax Rs m9,33615,168 61.5%  
Gross profit margin %23.520.2 116.5%  
Effective tax rate %14.28.0 177.6%   
Net profit margin %15.916.1 99.1%  
BALANCE SHEET DATA
Current assets Rs m53,84160,223 89.4%   
Current liabilities Rs m31,61253,058 59.6%   
Net working cap to sales %38.07.6 499.5%  
Current ratio x1.71.1 150.1%  
Inventory Days Days9770 139.2%  
Debtors Days Days8488 95.0%  
Net fixed assets Rs m42,07972,984 57.7%   
Share capital Rs m8461,024 82.6%   
"Free" reserves Rs m42,65568,576 62.2%   
Net worth Rs m43,50169,600 62.5%   
Long term debt Rs m22,40824,684 90.8%   
Total assets Rs m101,250152,207 66.5%  
Interest coverage x6.336.8 17.1%   
Debt to equity ratio x0.50.4 145.2%  
Sales to assets ratio x0.60.6 93.4%   
Return on assets %11.310.3 109.6%  
Return on equity %21.521.8 98.5%  
Return on capital %19.617.9 109.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m20,06621,280 94.3%   
Fx outflow Rs m5,30410,874 48.8%   
Net fx Rs m14,76210,406 141.9%   
CASH FLOW
From Operations Rs m10,12713,495 75.0%  
From Investments Rs m-7,869-29,103 27.0%  
From Financial Activity Rs m-1,91823,158 -8.3%  
Net Cashflow Rs m2127,556 2.8%  

Share Holding

Indian Promoters % 71.5 74.8 95.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.0 8.3 84.6%  
FIIs % 12.6 5.9 213.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.8 11.0 80.0%  
Shareholders   26,511 44,069 60.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  CIPLA  ASTRAZENECA PHARMA  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Energy and IT Stocks Witness Buying(12:30 pm)

Stock markets in India are presently trading on a positive note. Sectoral indices are trading on a positive note with stocks in the energy sector and IT sector witnessing maximum buying interest.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


May 25, 2018 02:27 PM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS